Molecular cytogenetic characterization of a subtle interstitial del(3)(p25.3p26.2) in a patient with deletion 3p syndrome.

Deletion 3p syndrome is associated with characteristic facial features, growth failure, and mental retardation. Typically, individuals with deletion 3p syndrome have terminal deletions that result in loss of material from 3p25 to 3pter. We present a child with a clinical phenotype consistent with deletion 3p syndrome (ptosis, microcephaly, growth retardation, and developmental delay) and a subtle interstitial deletion in the distal portion of the short arm of chromosome 3, del(3)(p25.3p26.2). Fluorescence in situ hybridization (FISH) studies using 3p subtelomeric probes confirmed the terminal region of chromosome 3 was present. Sequence tagged sites (STS)-linked BAC clones mapping to chromosomal region 3p25-p26 were used to characterize the interstitial deletion by FISH. The results indicate the deletion is within a region of approximately 4.5 Mb between STS markers D3S3630 and D3S1304. This interstitial deletion lies within all previously reported terminal deletions in deletion 3p syndrome individuals, and represents the smallest reported deletion associated with deletion 3p syndrome. Characterization of the deletion may help identify genes important to growth and development that contribute to the deletion 3p syndrome phenotype when present in a hemizygous state.

[1]  M E Phipps,et al.  Molecular genetic analysis of the 3p- syndrome. , 1994, Human molecular genetics.

[2]  E. Green,et al.  Detailed mapping of a congenital heart disease gene in chromosome 3p25 , 2000, Journal of medical genetics.

[3]  L. Weiss,et al.  Mother and son with deletion of 3p25-pter. , 1991, American journal of medical genetics.

[4]  F. Sotgia,et al.  Localization of the human caveolin‐3 gene to the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene , 1999, FEBS letters.

[5]  K. Mikoshiba,et al.  Human inositol 1,4,5-trisphosphate type-1 receptor, InsP3R1: structure, function, regulation of expression and chromosomal localization. , 1994, The Biochemical journal.

[6]  E. Kerem,et al.  Partial deletion of the short arm of chromosome 3: further delineation of the 3p25 ‐ 3pter syndrome , 1986, Clinical genetics.

[7]  A. Ullrich,et al.  Molecular cloning of a cDNA for the human inositol 1,4,5-trisphosphate receptor type 1, and the identification of a third alternatively spliced variant. , 1995, Brain research. Molecular brain research.

[8]  N. Carter,et al.  Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. , 1992, Genomics.

[9]  J. Nef,et al.  A patient with a partial deletion of the short arm of chromosome 3. , 1978, American journal of diseases of children.

[10]  B. Mcgillivray,et al.  Precise localisation of 3p25 breakpoints in four patients with the 3p-syndrome. , 1996, Journal of medical genetics.

[11]  J. Mascarello,et al.  A second patient with partial deletion of the short arm of chromosome 3: karyotype 46,XY,del(3)(p25). , 1982, Journal of Medical Genetics.

[12]  J. Hall,et al.  Partial deletion of the short arm of chromosome 3 (3p25 → 3pter) Further delineation of the clinical phenotype , 1985, Clinical genetics.

[13]  K. Narahara,et al.  Loss of the 3p25.3 band is critical in the manifestation of del(3p) syndrome: karyotype-phenotype correlation in cases with deficiency of the distal portion of the short arm of chromosome 3. , 1990, American journal of medical genetics.

[14]  D. Pinkel,et al.  Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Freier,et al.  Complex FISH probes for the subtelomeric regions of all human chromosomes: comparative hybridization of CEPH YACs to chromosomes of the Old World monkey Presbytis cristata and great apes. , 1997, Cytogenetics and cell genetics.

[16]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[17]  M. Wei,et al.  CALL gene is haploinsufficient in a 3p- syndrome patient. , 1999, American journal of medical genetics.

[18]  M. Lerman,et al.  Clinical and molecular analyses of deletion 3p25-pter syndrome. , 1993, American journal of medical genetics.